InstalabLoading...
InstalabLoading...
Most people have never heard of serine, yet it sits at the crossroads of your brain, your nerves, your eyes, and your metabolism. When your levels drift too low, your body quietly starts making toxic fat-like molecules that damage nerves and the back of your retina. When they drift too high, different problems emerge, including connections to cancer risk and neurodegenerative disease.
This is a research-grade test without standardized clinical cutpoints yet, but that is exactly why a baseline now is useful. You get your own number, in your own body, and you can track how it shifts over years as the science matures around it.
Serine is a small amino acid, which is a building block your body uses to make proteins. Unlike some amino acids, you do not strictly need it in food because your cells can build it from scratch using an enzyme called PHGDH (phosphoglycerate dehydrogenase). Scientists now call serine conditionally essential, meaning that under stress, illness, or certain genetic patterns, your body's ability to make enough of it falls short.
Serine is a workhorse. It feeds the chemical pathway that builds DNA, recycles the molecules that cap off your antioxidant defenses (the glutathione system), and supplies the raw material for sphingolipids, the fatty insulation that coats your nerves and retinal cells. In the brain, serine gets converted into D-serine, a molecule that helps neurons talk to each other through NMDA receptors, a key part of memory and learning.
This is the most firmly established clinical story for serine. When levels run low, your body's lipid-building machinery misroutes and produces a class of harmful fats called deoxysphingolipids. These accumulate in the back of the retina and in peripheral nerves, and they damage both.
In people with macular telangiectasia type 2 (a progressive retinal disease that blurs central vision), blood serine runs roughly 20% lower than in healthy people. A meaningful fraction of cases trace back to inherited variants in PHGDH, the gene that makes the main serine-building enzyme. Similar biology drives HSAN1, an inherited nerve disease that causes sensory loss, pain, and foot wounds.
What this means for you: if your serine is on the low end and you are noticing subtle changes in central vision, tingling or numbness in your feet, or unexplained neuropathy, this is a finding worth taking to an eye specialist or neurologist. The connection between low serine and toxic nerve lipids is one of the best-supported reasons to know your number.
Your brain uses D-serine as a signaling molecule at the synapses between neurons. When this system runs too hot or too cold, cognition suffers. In Alzheimer's disease, D-serine and the ratio of D-serine to total serine are elevated in both blood and spinal fluid, and higher levels track with worse cognitive scores. In Parkinson's disease, both L- and D-serine rise in the spinal fluid and in the brain's caudate region, creating what researchers describe as a Parkinson's-specific signature.
In frail older adults, serum patterns of serine and glycine (a closely related amino acid) predict cognitive decline and depressive symptoms. In chronic kidney disease, the picture flips: lower L-serine in the brain and blood tracks with worse cognitive function, particularly in people on dialysis.
Cancer cells love serine. They hijack the serine synthesis pathway to build DNA for rapid growth, manage oxidative stress, and resist chemotherapy and radiation. In a nested case-control study of Chinese hypertensive adults, higher baseline serum serine was associated with increased risk of developing overall and lung cancers, and a separate analysis within the same cohort linked serum serine to higher all-cause mortality.
Serine also shows up in liver and metabolic disease. In people with non-alcoholic fatty liver disease, a combined glutamate-serine-glycine index reflects insulin resistance and the severity of liver scarring. Genetic analyses in over 130,000 people suggest that being born with a predisposition to higher serum serine is causally linked to a higher risk of multiple sclerosis and faster disability progression.
You may have noticed something strange: low serine is bad for your eyes and nerves, but high serine is bad for your cancer risk and possibly your MS risk. This is not a contradiction. Serine is not a simple good-number, bad-number marker. It is a phenotype indicator, meaning it reveals which metabolic pathway is dominant in your body right now. Too little and you cannot make protective lipids or support one-carbon metabolism. Too much, particularly alongside insulin resistance or a cancer-prone environment, and you may be fueling biology you do not want fueled. This is why pairing your serine number with kidney function, liver function, and other amino acids (especially glycine) makes the result far more informative than serine alone.
Serine is a research and exploratory marker. Major clinical guidelines do not yet define reference intervals or risk thresholds. Reference values from healthy cohorts exist but vary by population, age, sex, and assay, so these are orientation, not universal targets. A large study of 9,575 Japanese adults using standardized amino acid profiling found that serine concentrations are more strongly related to sex than to age or body mass index, and recommended sex-stratified reference intervals. Your lab will likely report its own range, possibly in different units.
| Context | Direction Seen | Source Population |
|---|---|---|
| Macular telangiectasia type 2 | About 20% lower than healthy controls | Gantner et al., 240 participants |
| Chronic kidney disease (non-dialysis) | Higher L-serine vs controls | Iwata et al., 100 participants |
| Chronic kidney disease (on dialysis) | Lower L-serine, linked to worse cognition | Iwata et al., 100 participants |
| Hypertensive adults with incident cancer | Higher baseline serine linked to cancer risk | Liu et al., 2,782 participants |
Compare your results within the same lab over time for the most meaningful signal. A single number in isolation tells you far less than a trajectory.
Amino acids, including serine, show relatively low within-person variability day to day, which makes serial tracking useful. Still, a single value cannot tell you whether your biology is moving in a helpful direction. Get a baseline, retest in 3 to 6 months if you are making lifestyle changes or starting a supplement, and then at least annually to watch for drift. Because this is an exploratory marker, your most valuable data is your own history. By the time consensus cutpoints are published, you will have years of personal context to compare them against.
A single out-of-range serine value is not a diagnosis. It is a prompt to investigate. If your result is low and you have eye or nerve symptoms, pair it with a retinal exam and a neurology consultation, and consider running deoxysphingolipid testing (the specific lipid species that accumulate when serine is low). If your result is high and you have metabolic risk factors such as insulin resistance or a strong cancer family history, pair it with a full amino acid panel, kidney function, and a fasting insulin or HbA1c. If D-serine is disproportionately elevated relative to L-serine, that ratio itself has been associated with neurodegenerative disease and is worth tracking with a neurologist if you have cognitive concerns. This is the kind of marker where pattern matters more than any single reading.
Evidence-backed interventions that affect your Serine level
Serine is best interpreted alongside these tests.